Home » Topics » BioWorld Science

BioWorld Science
RSS

Carbapenems reported by Merck & Co.

Sep. 6, 1996

Merck & Co. describes antibiotics active against resistant staphylococci

Sep. 6, 1996

Japanese companies report cephems

Sep. 6, 1996

Allergen describes compounds with retinoid-like activity

Sep. 6, 1996

Interferon gamma-1b enters pivotal trials for atopic dermatitis

Sep. 6, 1996

ProCyte cleared for clinical trials with wound-healing product

Sep. 6, 1996

ProCyte issued patents covering hair loss applications

Sep. 6, 1996

Ornithine decarboxylase inhibitors for dermatology

Sep. 6, 1996

BTG licenses analgesic combination to Forest

Sep. 6, 1996

Xoma/Genentech to commence clinical trials with humanized monoclonal antibody

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...